EP4 - Tim Kirby, CEO of Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals discuss strategies for expanding the medical cannabis market in the UK. They highlight the challenges in the current market, such as patient accessibility and supply chain issues, emphasise the importance of vertical integration and advanced…

EP3 - In this special edition episode, Releaf COO Graham Woodward sits down with cannabinoid pharmacologist Professor Saoirse O’Sullivan to explore whether our current approach to cannabis-based treatment is truly evidence-led or built on outdated myths. From the science behind THC and CBD to the truth about the entourage effect, this episode chall…

EP2 - Robert Jappie, partner at Fieldfisher LLP and Tim Kirby, CEO at Releaf unpack the challenges and opportunities shaping the UK’s medical cannabis landscape, from the slow-moving regulatory environment to the urgent need for patient-focused innovation. Key topics include: - Why the UK's medical cannabis framework has barely shifted since legali…

EP1 - CEOs Tim Kirby of Releaf and James Duckenfield of Glass Pharm sat down to discuss the ever-evolving UK medical cannabis sector. In 2024, we joined forces with Glass Pharms in the UK's largest ever medical cannabis deal, providing Releaf patients with a consistent, high-quality supply of domestic grown CBPMs. As one of the most-trusted #medica…